EBITDA: Income before interest, taxes, depreciation and amortization.
Boundless Bio, Inc. (BOLD) had EBITDA of $-23.13M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-23.69M |
|
-- |
|
-- |
|
$24.38M |
|
$-24.38M |
|
$0.69M |
|
$-23.69M |
|
$-23.69M |
|
$-23.69M |
|
$-23.69M |
|
$-23.69M |
|
$-23.69M |
|
$-24.38M |
|
|
EBITDA |
$-23.13M |
22.45M |
|
22.45M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$73.65M |
|
$0.10M |
|
$0.10M |
|
$73.74M |
|
$7.77M |
|
-- |
|
-- |
|
$7.77M |
|
$65.98M |
|
$65.98M |
|
$65.98M |
|
22.48M |
|
| Cash Flow Statement Financials | |
$-35.95M |
|
$37.66M |
|
$0.07M |
|
$18.43M |
|
$20.21M |
|
$1.78M |
|
$4.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.91% |
|
-35.91% |
|
-32.13% |
|
-35.91% |
|
$2.94 |
|
$-1.60 |
|
$-1.60 |
|